Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

NCT00956007 is registered in ClinicalTrials.gov with Radiation Therapy Oncology Group as lead sponsor.

NCT NCT00956007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00956007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Lead sponsor
Radiation Therapy Oncology Group
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 31, 2010
Completion date
August 31, 2029
Enrollment
702 (actual)
Sites
264

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer